157 related articles for article (PubMed ID: 35504885)
21. Novel germline TRAF3IP3 mutation in a dyad with familial acute B lymphoblastic leukemia.
Pommert L; Burns R; Furumo Q; Pulakanti K; Brandt J; Burke MJ; Rao S
Cancer Rep (Hoboken); 2021 Jun; 4(3):e1335. PubMed ID: 33503336
[TBL] [Abstract][Full Text] [Related]
22. Umbilical cord blood‑derived Helios‑positive regulatory T cells promote angiogenesis in acute lymphoblastic leukemia in mice via CCL22 and the VEGFA‑VEGFR2 pathway.
Li X; Li D; Shi Q; Huang X; Ju X
Mol Med Rep; 2019 May; 19(5):4195-4204. PubMed ID: 30896872
[TBL] [Abstract][Full Text] [Related]
23. Overexpression of forkhead box C1 promotes tumor metastasis and indicates poor prognosis in hepatocellular carcinoma.
Xia L; Huang W; Tian D; Zhu H; Qi X; Chen Z; Zhang Y; Hu H; Fan D; Nie Y; Wu K
Hepatology; 2013 Feb; 57(2):610-24. PubMed ID: 22911555
[TBL] [Abstract][Full Text] [Related]
24. Exome Sequencing in a Swiss Childhood Glaucoma Cohort Reveals
Lang E; Koller S; Bähr L; Töteberg-Harms M; Atac D; Roulez F; Bahr A; Steindl K; Feil S; Berger W; Gerth-Kahlert C
Transl Vis Sci Technol; 2020 Jun; 9(7):47. PubMed ID: 32832252
[TBL] [Abstract][Full Text] [Related]
25. Methylation of the promoter region of the MTRR gene in childhood acute lymphoblastic leukemia.
Bai J; Li L; Li Y; Chen Q; Zhang L; Xie X
Oncol Rep; 2019 Jun; 41(6):3488-3498. PubMed ID: 31002356
[TBL] [Abstract][Full Text] [Related]
26. Clinical Significance of MAP-7 and FOXC1 in Egyptian Acute Myeloid Leukemia Patients.
Nabawy SM; Refaat LA; Naser-Aldin HM; Rashed RA
Asian Pac J Cancer Prev; 2022 May; 23(5):1619-1626. PubMed ID: 35633546
[TBL] [Abstract][Full Text] [Related]
27. The wing 2 region of the FOXC1 forkhead domain is necessary for normal DNA-binding and transactivation functions.
Murphy TC; Saleem RA; Footz T; Ritch R; McGillivray B; Walter MA
Invest Ophthalmol Vis Sci; 2004 Aug; 45(8):2531-8. PubMed ID: 15277473
[TBL] [Abstract][Full Text] [Related]
28. Treatment with rapamycin can restore regulatory T-cell function in IPEX patients.
Passerini L; Barzaghi F; Curto R; Sartirana C; Barera G; Tucci F; Albarello L; Mariani A; Testoni PA; Bazzigaluppi E; Bosi E; Lampasona V; Neth O; Zama D; Hoenig M; Schulz A; Seidel MG; Rabbone I; Olek S; Roncarolo MG; Cicalese MP; Aiuti A; Bacchetta R
J Allergy Clin Immunol; 2020 Apr; 145(4):1262-1271.e13. PubMed ID: 31874182
[TBL] [Abstract][Full Text] [Related]
29. The Role of hsa-miR-548l Dysregulation as a Putative Modifier Factor for Glaucoma-Associated FOXC1 Mutations.
Medina-Trillo C; Aroca-Aguilar JD; Ferre-Fernández JJ; Méndez-Hernández CD; Morales L; García-Feijoo J; Escribano J
Microrna; 2015; 4(1):50-6. PubMed ID: 25809640
[TBL] [Abstract][Full Text] [Related]
30. PTPRG inhibition by DNA methylation and cooperation with RAS gene activation in childhood acute lymphoblastic leukemia.
Xiao J; Lee ST; Xiao Y; Ma X; Houseman EA; Hsu LI; Roy R; Wrensch M; de Smith AJ; Chokkalingam A; Buffler P; Wiencke JK; Wiemels JL
Int J Cancer; 2014 Sep; 135(5):1101-9. PubMed ID: 24496747
[TBL] [Abstract][Full Text] [Related]
31. CRTAM
Ramírez-Ramírez D; Padilla-Castañeda S; Galán-Enríquez CS; Vadillo E; Prieto-Chávez JL; Jiménez-Hernández E; Vilchis-Ordóñez A; Sandoval A; Balandrán JC; Pérez-Tapia SM; Ortiz-Navarrete V; Pelayo R
J Leukoc Biol; 2019 May; 105(5):999-1013. PubMed ID: 30791148
[TBL] [Abstract][Full Text] [Related]
32. BACH2-mediated FOS confers cytarabine resistance via stromal microenvironment alterations in pediatric ALL.
Zhang H; Zhang R; Zheng X; Sun M; Fan J; Fang C; Tian X; Zheng H
Cancer Sci; 2021 Mar; 112(3):1235-1250. PubMed ID: 33393145
[TBL] [Abstract][Full Text] [Related]
33. PITX2 and FOXC1 spectrum of mutations in ocular syndromes.
Reis LM; Tyler RC; Volkmann Kloss BA; Schilter KF; Levin AV; Lowry RB; Zwijnenburg PJ; Stroh E; Broeckel U; Murray JC; Semina EV
Eur J Hum Genet; 2012 Dec; 20(12):1224-33. PubMed ID: 22569110
[TBL] [Abstract][Full Text] [Related]
34. Analyses of a novel L130F missense mutation in FOXC1.
Ito YA; Footz TK; Murphy TC; Courtens W; Walter MA
Arch Ophthalmol; 2007 Jan; 125(1):128-35. PubMed ID: 17210863
[TBL] [Abstract][Full Text] [Related]
35. Critical stoichiometric ratio of CD4(+) CD25(+) FoxP3(+) regulatory T cells and CD4(+) CD25(-) responder T cells influence immunosuppression in patients with B-cell acute lymphoblastic leukaemia.
Bhattacharya K; Chandra S; Mandal C
Immunology; 2014 May; 142(1):124-39. PubMed ID: 24354800
[TBL] [Abstract][Full Text] [Related]
36. Promoter methylation and expression of SOCS3 affect the clinical outcome of pediatric acute lymphoblastic leukemia by JAK/STAT pathway.
Liu K; Wu Z; Chu J; Yang L; Wang N
Biomed Pharmacother; 2019 Jul; 115():108913. PubMed ID: 31054507
[TBL] [Abstract][Full Text] [Related]
37. Regulation of CD4
El-Maadawy EA; Elshal MF; Bakry RM; Moussa MM; El-Naby S; Talaat RM
Mol Immunol; 2020 Aug; 124():1-8. PubMed ID: 32480291
[TBL] [Abstract][Full Text] [Related]
38. Severe molecular defects of a novel FOXC1 W152G mutation result in aniridia.
Ito YA; Footz TK; Berry FB; Mirzayans F; Yu M; Khan AO; Walter MA
Invest Ophthalmol Vis Sci; 2009 Aug; 50(8):3573-9. PubMed ID: 19279310
[TBL] [Abstract][Full Text] [Related]
39. The forkhead box C1 (FOXC1) transcription factor is downregulated in acute promyelocytic leukemia.
Fabiani E; Falconi G; Noguera NI; Saulle E; Cicconi L; Divona M; Banella C; Picardi A; Cerio AM; Boe L; Sanchez M; Pelosi E; Testa U; Lo-Coco F; Voso MT
Oncotarget; 2017 Oct; 8(48):84074-84085. PubMed ID: 29137406
[TBL] [Abstract][Full Text] [Related]
40. Release of IFNγ by Acute Myeloid Leukemia Cells Remodels Bone Marrow Immune Microenvironment by Inducing Regulatory T Cells.
Corradi G; Bassani B; Simonetti G; Sangaletti S; Vadakekolathu J; Fontana MC; Pazzaglia M; Gulino A; Tripodo C; Cristiano G; Bandini L; Ottaviani E; Ocadlikova D; Piccioli M; Martinelli G; Colombo MP; Rutella S; Cavo M; Ciciarello M; Curti A
Clin Cancer Res; 2022 Jul; 28(14):3141-3155. PubMed ID: 35349670
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
